Combining Anti-ERBB3 Antibodies Specific for Domain I and Domain III Enhances the Anti-Tumor Activity over the Individual Monoclonal Antibodies
Jimson W. D’Souza(Fox Chase Cancer Center), Matthew K. Robinson(Allen Institute)
Cited by 11
Related Papers
No related papers found
Powered by citation graph analysis